Risk of Suicidal Behavior With Use of Efavirenz: Results from the Strategic Timing of Antiretroviral Treatment Trial

Arenas-Pinto, A; Grund, B; Sharma, S; Martinez, E; Cummins, N; Fox, J; Klingman, KL; ... INSIGHT START study group, .; + view all Arenas-Pinto, A; Grund, B; Sharma, S; Martinez, E; Cummins, N; Fox, J; Klingman, KL; Sedlacek, D; Collins, S; Flynn, PM; Chasanov, WM; Kedem, E; Katlama, C; Sierra-Madero, J; Afonso, C; Brouwers, P; Cooper, DA; INSIGHT START study group, .; - view fewer (2018) Risk of Suicidal Behavior With Use of Efavirenz: Results from the Strategic Timing of Antiretroviral Treatment Trial. Clinical Infectious Diseases 10.1093/cid/ciy051 . (In press).

http://ift.tt/2DPmHyI